Opinion
Video
Hormonal Adaptations in Type 2 Diabetes and Obesity
Author(s):
Panelists discuss how hormonal adaptations during weight loss in diabetes patients improve insulin sensitivity, while the DiRECT trial demonstrates that structured weight management programs can achieve diabetes remission in nearly half of newly diagnosed patients.
Introduction and Hormonal Adaptations
This peer exchange program focuses on advancing care for type 2 diabetes and obesity through a coordinated, guideline-driven approach. The discussion begins with an exploration of hormonal adaptations that occur when patients with diabetes experience weight changes. Approximately 80% of patients with type 2 diabetes also have obesity, and weight loss significantly benefits insulin sensitivity by reducing ectopic fat in the pancreas and liver. Weight loss triggers beneficial neuroendocrine changes including alterations in leptin, ghrelin, insulin, cortisol, and other appetite-regulating gut hormones.
However, weight regain can reverse these beneficial metabolic changes, presenting ongoing clinical challenges. The complex interplay between diabetes and obesity requires understanding of the underlying pathophysiology to effectively manage patients. This biological framework becomes essential for implementing comprehensive treatment strategies that address both conditions simultaneously rather than treating them as separate entities.
The discussion establishes that successful management requires recognition of the interconnected nature of these conditions and the hormonal mechanisms that influence both weight regulation and glucose control. This foundational understanding sets the stage for exploring evidence-based interventions and systematic approaches to patient care.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
